87 related articles for article (PubMed ID: 10467347)
1. Benzamide riboside induces apoptosis independent of Cdc25A expression in human ovarian carcinoma N.1 cells.
Grusch M; Rosenberger G; Fuhrmann G; Braun K; Titscher B; Szekeres T; Fritzer-Skekeres M; Oberhuber G; Krohn K; Hengstschlaeger M; Krupitza G; Jayaram HN
Cell Death Differ; 1999 Aug; 6(8):736-44. PubMed ID: 10467347
[TBL] [Abstract][Full Text] [Related]
2. Benzamide riboside induced mitochondrial mediated apoptosis in human lung cancer H520 cells.
Khanna N; Jayaram HN; Singh N
Life Sci; 2004 May; 75(2):179-90. PubMed ID: 15120570
[TBL] [Abstract][Full Text] [Related]
3. Biochemical consequences of resistance to a recently discovered IMP dehydrogenase inhibitor, benzamide riboside, in human myelogenous leukemia K562 cells.
Jayaram HN; O'Connor A; Grant MR; Yang H; Grieco PA; Cooney DA
J Exp Ther Oncol; 1996 Sep; 1(5):278-85. PubMed ID: 9414415
[TBL] [Abstract][Full Text] [Related]
4. Consequences of IMP dehydrogenase inhibition, and its relationship to cancer and apoptosis.
Jayaram HN; Cooney DA; Grusch M; Krupitza G
Curr Med Chem; 1999 Jul; 6(7):561-74. PubMed ID: 10390601
[TBL] [Abstract][Full Text] [Related]
5. TNFalpha-mediated cell death is independent of cdc25A.
Krupitza G; Grusch M; Braun K; Fuhrmann G; Steinbrugger R; Hulla W; Simonitsch I; Chott A; Hengstschläger M
Cell Death Differ; 1998 Sep; 5(9):758-64. PubMed ID: 10200535
[TBL] [Abstract][Full Text] [Related]
6. Metabolism of the novel IMP dehydrogenase inhibitor benzamide riboside.
Jäger W; Salamon A; Szekeres T
Curr Med Chem; 2002 Apr; 9(7):781-6. PubMed ID: 11966442
[TBL] [Abstract][Full Text] [Related]
7. Potential mechanisms of benzamide riboside mediated cell death.
Polgar D; Gfatter S; Uhl M; Kassie F; Leisser C; Krupitza G; Grusch M
Curr Med Chem; 2002 Apr; 9(7):765-71. PubMed ID: 11966440
[TBL] [Abstract][Full Text] [Related]
8. Staurosporine enhanced benzamide riboside-induced apoptosis in human multidrug-resistant promyelocytic leukemia cells (HL-60/VCR) in vitro.
Hunáková L; Duraj J; Romanová D; Novotný L; Sedlák J; Kelley MR; Szekeres T; Jayaram HN; Chorváth B
Neoplasma; 1998; 45(4):204-9. PubMed ID: 9890662
[TBL] [Abstract][Full Text] [Related]
9. Differential sensitivity of ovarian carcinoma cell lines to apoptosis induced by the IMPDH inhibitor benzamide riboside.
Hunáková L; Bies J; Sedlák J; Duraj J; Jakubíková J; Takácsová X; Novotný L; Chorváth B
Neoplasma; 2000; 47(5):274-9. PubMed ID: 11130242
[TBL] [Abstract][Full Text] [Related]
10. Molecular targets of guanine nucleotides in differentiation, proliferation and apoptosis.
Yalowitz JA; Jayaram HN
Anticancer Res; 2000; 20(4):2329-38. PubMed ID: 10953293
[TBL] [Abstract][Full Text] [Related]
11. 3-Hydrogenkwadaphnin targets inosine 5'-monophosphate dehydrogenase and triggers post-G1 arrest apoptosis in human leukemia cell lines.
Moosavi MA; Yazdanparast R; Sanati MH; Nejad AS
Int J Biochem Cell Biol; 2005 Nov; 37(11):2366-79. PubMed ID: 16084123
[TBL] [Abstract][Full Text] [Related]
12. Studies on the mechanism of action of benzamide riboside: a novel inhibitor of IMP dehydrogenase.
Gharehbaghi K; Grünberger W; Jayaram HN
Curr Med Chem; 2002 Apr; 9(7):743-8. PubMed ID: 11966437
[TBL] [Abstract][Full Text] [Related]
13. Benzamide riboside, a recent inhibitor of inosine 5'-monophosphate dehydrogenase induces transferrin receptors in cancer cells.
Szekeres T; Sedlak J; Novotny L
Curr Med Chem; 2002 Apr; 9(7):759-64. PubMed ID: 11966439
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxicity and characterization of an active metabolite of benzamide riboside, a novel inhibitor of IMP dehydrogenase.
Gharehbaghi K; Paull KD; Kelley JA; Barchi JJ; Marquez VE; Cooney DA; Monks A; Scudiero D; Krohn K; Jayaram HN
Int J Cancer; 1994 Mar; 56(6):892-9. PubMed ID: 7907081
[TBL] [Abstract][Full Text] [Related]
15. Modulation of cytotoxicity of benzamide riboside by expression of NMN adenylyltransferase.
Yalowitz JA; Jayaram HN
Curr Med Chem; 2002 Apr; 9(7):749-58. PubMed ID: 11966438
[TBL] [Abstract][Full Text] [Related]
16. Antitumor activity of benzamide riboside in vitro and in vivo.
Novotny L; Rauko P; Yalowitz JA; Szekeres T
Curr Med Chem; 2002 Apr; 9(7):773-9. PubMed ID: 11966441
[TBL] [Abstract][Full Text] [Related]
17. The histone deacetylase inhibitor sodium butyrate induces breast cancer cell apoptosis through diverse cytotoxic actions including glutathione depletion and oxidative stress.
Louis M; Rosato RR; Brault L; Osbild S; Battaglia E; Yang XH; Grant S; Bagrel D
Int J Oncol; 2004 Dec; 25(6):1701-11. PubMed ID: 15547708
[TBL] [Abstract][Full Text] [Related]
18. Modulation of bcl-2 family proteins in MAPK independent apoptosis induced by a cdc25 phosphatase inhibitor Cpd 5 in renal cancer cells.
Mizuno R; Oya M; Hara S; Matsumoto M; Horiguchi A; Ohigashi T; Marumo K; Murai M
Oncol Rep; 2005 Sep; 14(3):639-44. PubMed ID: 16077967
[TBL] [Abstract][Full Text] [Related]
19. Suppression of human ovarian SKOV-3 cancer cell growth by Duchesnea phenolic fraction is associated with cell cycle arrest and apoptosis.
Peng B; Chang Q; Wang L; Hu Q; Wang Y; Tang J; Liu X
Gynecol Oncol; 2008 Jan; 108(1):173-81. PubMed ID: 17959232
[TBL] [Abstract][Full Text] [Related]
20. Effect of BPV1 E2-mediated inhibition of E6/E7 expression in HPV16-positive cervical carcinoma cells.
Moon MS; Lee CJ; Um SJ; Park JS; Yang JM; Hwang ES
Gynecol Oncol; 2001 Feb; 80(2):168-75. PubMed ID: 11161855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
